IAVI, CureVac team up to accelerate AIDS vaccine development; GeoVax Ebola jab reports 100% protection in animal study;

> The International AIDS Vaccine Initiative (IAVI) is partnering with CureVac to accelerate the development of AIDS vaccines. Release

> GeoVax's Ebola vaccine posts 100% protection in guinea pigs and Syrian golden hamsters. More

> Walvax Biotechnology is using Medidata's ($MDSO) cloud-based platform to advance the development of a pediatric pneumococcal vaccine in China. Release

> Researchers at VIB and Ghent University in Belgium found a link between exposure to "farm dust" and protection against asthma and allergies. Release

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.

Takeda has spent considerable resources on its phase 3 dengue vaccine, and now data show the shot was 80% effective in preventing dengue.